Multidrug resistance and prodrug activation for cancer gene therapy of breast cancer

Takuma Fujii, S. Q. Fu, L. H. Yin, T. Nanakorn, Felix Garcia Sanchez, Matt Cooperberg, David Guo, Tao Wang, D. Lin, Giuseppe Pizzorno, Albert Deisseroth

Research output: Contribution to journalArticle

Abstract

Current approaches to the treatment of cancer (radiation and chemotherapy) are limited by the toxicity to normal tissues and the sensitivity of tumor cells to these treatments. The use of gene delivery vector systems for the introduction of genetic elements into normal and neoplastic tissues which code for proteins that protect the normal chemotherapy-sensitive tissues and sensitize the tumor cells to radiation and chemotherapy, may contribute to an overall improvement in the outcome of cancer treatment programs. This chapter will review the clinical trials either completed or about to be initiated which are designed to accomplish these goals.

Original languageEnglish
Pages (from-to)210-212
Number of pages3
JournalBreast Cancer
Volume4
Issue number4
DOIs
Publication statusPublished - 01-12-1997

Fingerprint

Neoplasm Genes
Prodrugs
Multiple Drug Resistance
Genetic Therapy
Breast Neoplasms
Drug Therapy
Neoplasms
Radiation
Gene Transfer Techniques
Clinical Trials
Therapeutics
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)

Cite this

Fujii, T., Fu, S. Q., Yin, L. H., Nanakorn, T., Sanchez, F. G., Cooperberg, M., ... Deisseroth, A. (1997). Multidrug resistance and prodrug activation for cancer gene therapy of breast cancer. Breast Cancer, 4(4), 210-212. https://doi.org/10.1007/BF02966508
Fujii, Takuma ; Fu, S. Q. ; Yin, L. H. ; Nanakorn, T. ; Sanchez, Felix Garcia ; Cooperberg, Matt ; Guo, David ; Wang, Tao ; Lin, D. ; Pizzorno, Giuseppe ; Deisseroth, Albert. / Multidrug resistance and prodrug activation for cancer gene therapy of breast cancer. In: Breast Cancer. 1997 ; Vol. 4, No. 4. pp. 210-212.
@article{2afdde93e97a4f12bd310696188232ce,
title = "Multidrug resistance and prodrug activation for cancer gene therapy of breast cancer",
abstract = "Current approaches to the treatment of cancer (radiation and chemotherapy) are limited by the toxicity to normal tissues and the sensitivity of tumor cells to these treatments. The use of gene delivery vector systems for the introduction of genetic elements into normal and neoplastic tissues which code for proteins that protect the normal chemotherapy-sensitive tissues and sensitize the tumor cells to radiation and chemotherapy, may contribute to an overall improvement in the outcome of cancer treatment programs. This chapter will review the clinical trials either completed or about to be initiated which are designed to accomplish these goals.",
author = "Takuma Fujii and Fu, {S. Q.} and Yin, {L. H.} and T. Nanakorn and Sanchez, {Felix Garcia} and Matt Cooperberg and David Guo and Tao Wang and D. Lin and Giuseppe Pizzorno and Albert Deisseroth",
year = "1997",
month = "12",
day = "1",
doi = "10.1007/BF02966508",
language = "English",
volume = "4",
pages = "210--212",
journal = "Breast Cancer",
issn = "1340-6868",
publisher = "Springer Japan",
number = "4",

}

Fujii, T, Fu, SQ, Yin, LH, Nanakorn, T, Sanchez, FG, Cooperberg, M, Guo, D, Wang, T, Lin, D, Pizzorno, G & Deisseroth, A 1997, 'Multidrug resistance and prodrug activation for cancer gene therapy of breast cancer', Breast Cancer, vol. 4, no. 4, pp. 210-212. https://doi.org/10.1007/BF02966508

Multidrug resistance and prodrug activation for cancer gene therapy of breast cancer. / Fujii, Takuma; Fu, S. Q.; Yin, L. H.; Nanakorn, T.; Sanchez, Felix Garcia; Cooperberg, Matt; Guo, David; Wang, Tao; Lin, D.; Pizzorno, Giuseppe; Deisseroth, Albert.

In: Breast Cancer, Vol. 4, No. 4, 01.12.1997, p. 210-212.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multidrug resistance and prodrug activation for cancer gene therapy of breast cancer

AU - Fujii, Takuma

AU - Fu, S. Q.

AU - Yin, L. H.

AU - Nanakorn, T.

AU - Sanchez, Felix Garcia

AU - Cooperberg, Matt

AU - Guo, David

AU - Wang, Tao

AU - Lin, D.

AU - Pizzorno, Giuseppe

AU - Deisseroth, Albert

PY - 1997/12/1

Y1 - 1997/12/1

N2 - Current approaches to the treatment of cancer (radiation and chemotherapy) are limited by the toxicity to normal tissues and the sensitivity of tumor cells to these treatments. The use of gene delivery vector systems for the introduction of genetic elements into normal and neoplastic tissues which code for proteins that protect the normal chemotherapy-sensitive tissues and sensitize the tumor cells to radiation and chemotherapy, may contribute to an overall improvement in the outcome of cancer treatment programs. This chapter will review the clinical trials either completed or about to be initiated which are designed to accomplish these goals.

AB - Current approaches to the treatment of cancer (radiation and chemotherapy) are limited by the toxicity to normal tissues and the sensitivity of tumor cells to these treatments. The use of gene delivery vector systems for the introduction of genetic elements into normal and neoplastic tissues which code for proteins that protect the normal chemotherapy-sensitive tissues and sensitize the tumor cells to radiation and chemotherapy, may contribute to an overall improvement in the outcome of cancer treatment programs. This chapter will review the clinical trials either completed or about to be initiated which are designed to accomplish these goals.

UR - http://www.scopus.com/inward/record.url?scp=84863241106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863241106&partnerID=8YFLogxK

U2 - 10.1007/BF02966508

DO - 10.1007/BF02966508

M3 - Article

AN - SCOPUS:84863241106

VL - 4

SP - 210

EP - 212

JO - Breast Cancer

JF - Breast Cancer

SN - 1340-6868

IS - 4

ER -